Misbah Noshela Ghazanfar
6PUBLICATIONS
6CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 29, 2023
Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria.Katrine Baumann, Astrid-Helene Ravn Jørgensen, Jennifer Astrup Sørensen
|Mar 12, 2022
Omalizumab serum levels predict treatment outcomes in patients with chronic spontaneous urticaria: A three-month prospective study.Misbah Noshela Ghazanfar, Ewa Anna Bartko, Nicolai Skovbjerg Arildsen
|Jan 15, 2021
Biological treatment of palmoplantar pustulosis: Long-term experience in 10 patients.Misbah Noshela Ghazanfar, Astrid-Helene Ravn Jørgensen, Simon Francis Thomsen
|Jul 13, 2020
Omalizumab for cholinergic urticaria: 6 months prospective study and systematic review of the literature.Misbah Noshela Ghazanfar, Jesper Grønlund Holm, Simon Francis Thomsen
|May 03, 2020
Fluctuations in serum levels of adalimumab and infliximab in patients on stable treatment for psoriasis.Anne Sofie Konstantin Poulsen, Simon Francis Thomsen, Caroline Vinkel
|Apr 10, 2019
Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab.Astrid C Chodziuk, Misbah N Ghazanfar, Simon F Thomsen
Pageof 1
